Cargando…

Evaluation of anidulafungin in the treatment of intra-abdominal candidiasis: a pooled analysis of patient-level data from 5 prospective studies

The incidence of nosocomial invasive fungal infections involving Candida spp. has increased markedly in recent years in patients undergoing abdominal surgery. This post hoc analysis aimed to determine the efficacy and safety of anidulafungin treatment in patients with intra-abdominal candidiasis (IA...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sganga, Gabriele, Wang, Minggui, Capparella, M. Rita, Tawadrous, Margaret, Yan, Jean L., Aram, Jalal A., Montravers, Philippe
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2019
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6778589/ https://www.ncbi.nlm.nih.gov/pubmed/31280481 http://dx.doi.org/10.1007/s10096-019-03617-9

Ejemplares similares

Invasive Candidiasis in Patients with Solid Tumors Treated with Anidulafungin: A Post Hoc Analysis of Efficacy and Safety of Six Pooled Studies
por: De Rosa, Francesco Giuseppe, et al.
Publicado: (2021)

Safety and Efficacy of Anidulafungin in the Treatment of Invasive Candidiasis in Children
por: Roilides, Emmanuel, et al.
Publicado: (2017)

Efficacy of anidulafungin in 539 patients with invasive candidiasis: a patient-level pooled analysis of six clinical trials
por: Kullberg, Bart Jan, et al.
Publicado: (2017)

Anidulafungin for candidemia/invasive candidiasis in non-neutropenic ICU patients
por: Ruhnke, M, et al.
Publicado: (2011)

Safety, Efficacy and Pharmacokinetics of Anidulafungin in Patients 1 Month to <2 Years of Age With Invasive Candidiasis, Including Candidemia
por: Roilides, Emmanuel, et al.
Publicado: (2020)

Anidulafungin for the treatment of candidaemia/invasive candidiasis in selected critically ill patients
por: Ruhnke, M, et al.
Publicado: (2012)

Population Analysis of Anidulafungin in Infants to Older Adults With Confirmed or Suspected Invasive Candidiasis
por: Xie, Rujia, et al.
Publicado: (2020)

Retrospective cohort study comparing the risk of severe hepatotoxicity in hospitalized patients treated with echinocandins for invasive candidiasis in the presence of confounding by indication
por: Vekeman, Francis, et al.
Publicado: (2018)

Safety, Efficacy, and Exposure–Response of Voriconazole in Pediatric Patients With Invasive Aspergillosis, Invasive Candidiasis or Esophageal Candidiasis
por: Martin, Judith M., et al.
Publicado: (2017)

Treatment and prophylaxis of invasive candidiasis with anidulafungin, caspofungin and micafungin - review of the literature
por: Glöckner, A
Publicado: (2011)

Cost-effectiveness analysis of anidulafungin for the treatment of candidaemia and other forms of invasive candidiasis
por: Auzinger, Georg, et al.
Publicado: (2015)

Micafungin versus anidulafungin in critically ill patients with invasive candidiasis: a retrospective study
por: van der Geest, Patrick J., et al.
Publicado: (2016)

Anidulafungin compared with fluconazole in severely ill patients with candidemia and other forms of invasive candidiasis: Support for the 2009 IDSA treatment guidelines for candidiasis
por: Kett, Daniel H, et al.
Publicado: (2011)

Antimicrobial Treatmdent of "Complicated" Intra-Abdominal Infections and The New IDSA Guidelines - A Commentary and an Alternative European Approach According to Clinical Definitions
por: Eckmann, C, et al.
Publicado: (2011)

Treatment and prophylaxis of invasive candidiasis with anidulafungin, caspofungin and micafungin and its impact on use and costs - review of the literature
por: Wilke, MH
Publicado: (2011)

Performance of the T2Candida Panel for the Diagnosis of Intra-abdominal Candidiasis
por: Lamoth, Frederic, et al.
Publicado: (2020)

Reappraisal of intra-abdominal candidiasis: insights from peritoneal fluid analysis
por: Novy, Emmanuel, et al.
Publicado: (2023)

A Randomized, Placebo-controlled Trial of Preemptive Antifungal Therapy for the Prevention of Invasive Candidiasis Following Gastrointestinal Surgery for Intra-abdominal Infections
por: Knitsch, Wolfgang, et al.
Publicado: (2015)

Early Empirical Anidulafungin Reduces the Prevalence of Invasive Candidiasis in Critically Ill Patients: A Case-control Study
por: Hasan, Md Jahidul, et al.
Publicado: (2022)

Cost-effectiveness analysis and budgetary impact of anidulafungin treatment for patients with candidemia and other forms of invasive candidiasis in Brazil
por: Vianna, Cid Manso de Mello, et al.
Publicado: (2023)

Antifungal activity of the piroctone olamine in experimental intra-abdominal candidiasis
por: do Couto, Fabíola Maria Marques, et al.
Publicado: (2016)

Unusual case of intra-abdominal candidiasis following laparoscopic hysterectomy
por: Wan, Kaijing, et al.
Publicado: (2019)

Risk Factors for Intra-Abdominal Candidiasis in Intensive Care Units: Results from EUCANDICU Study
por: Bassetti, Matteo, et al.
Publicado: (2022)

Intra-Abdominal Candidiasis: The Importance of Early Source Control and Antifungal Treatment
por: Vergidis, Pascalis, et al.
Publicado: (2016)

Evaluation of Invasive Intra-abdominal Candidiasis in Crohn Disease at the Time of Surgery
por: Šašala, Martin, et al.
Publicado: (2020)

β-D-glucan Surveillance with Preemptive Anidulafungin for Invasive Candidiasis in Intensive Care Unit Patients: A Randomized Pilot Study
por: Hanson, Kimberly E., et al.
Publicado: (2012)

Anidulafungin dosing during CRRT: do not underestimate adsorption!
por: Honore, Patrick M, et al.
Publicado: (2014)

Pharmacokinetic and pharmacodynamic considerations for antifungal therapy optimisation in the treatment of intra-abdominal candidiasis
por: Novy, Emmanuel, et al.
Publicado: (2023)

Anidulafungin in the treatment of invasive fungal infections
por: Sabol, Kathryn, et al.
Publicado: (2008)

Anidulafungin and its role in candida infections
por: Cappelletty, Diane M, et al.
Publicado: (2009)

Pharmacokinetics of anidulafungin during albumin dialysis
por: Aguilar, Gerardo, et al.
Publicado: (2014)

Does Weight Impact Anidulafungin Pharmacokinetics?
por: Lempers, Vincent J., et al.
Publicado: (2016)

Anidulafungin: Lack of efficacy: case report
Publicado: (2022)

Anidulafungin compared with fluconazole for treatment of candidemia and other forms of invasive candidiasis caused by Candida albicans: a multivariate analysis of factors associated with improved outcome
por: Reboli, Annette C, et al.
Publicado: (2011)

Invasive Fungal Infections in Infants—Focus on Anidulafungin
por: Wilke, Michael H.
Publicado: (2013)

Cost-effectiveness analysis of anidulafungin in the treatment of candidaemia
por: Auzinger, G, et al.
Publicado: (2013)

Anidulafungin/voriconazole: Lack of efficacy: case report
Publicado: (2022)

Anidulafungin/antibacterials: Failure of response: case report
Publicado: (2022)

Characteristics and outcomes of anti-infective de-escalation during health care-associated intra-abdominal infections
por: Montravers, Philippe, et al.
Publicado: (2016)

Anidulafungin compared with fluconazole therapy in critically ill patients
por: Kett, DH, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_0hn3kedcps5bndvhhfck3qh06j